Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GTP Bioways, formerly known as GTP Technology, is a leading French contract development and manufacturing organization (CDMO) specializing in the production of recombinant proteins and antibodies. The company offers a comprehensive suite of services ranging from cell line development and process optimization to GMP-compliant manufacturing for clinical trials. GTP Bioways utilizes a variety of expression systems, including mammalian, microbial, and insect cells, to produce complex biologics. Their expertise also extends to the formulation of nanomedicines and fill-finish services. As part of the Clean Biologics group, the company supports biopharmaceutical innovators in accelerating their drug development programs from discovery to the clinic.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GTP Technology.